Rare Immunology News
Advertisement
Disease Profile
Precocious puberty
Prevalence estimates on Rare Medical Network websites are calculated based on data available from numerous sources, including US and European government statistics, the NIH, Orphanet, and published epidemiologic studies. Rare disease population data is recognized to be highly variable, and based on a wide variety of source data and methodologies, so the prevalence data on this site should be assumed to be estimated and cannot be considered to be absolutely correct.
Unknown
Age of onset
Childhood
ICD-10
E22.8 E30.1
Inheritance
Autosomal dominant A pathogenic variant in only one gene copy in each cell is sufficient to cause an autosomal dominant disease.
Autosomal recessive Pathogenic variants in both copies of each gene of the chromosome are needed to cause an autosomal recessive disease and observe the mutant phenotype.
X-linked
dominant X-linked dominant inheritance, sometimes referred to as X-linked dominance, is a mode of genetic inheritance by which a dominant gene is carried on the X chromosome.
dominant X-linked dominant inheritance, sometimes referred to as X-linked dominance, is a mode of genetic inheritance by which a dominant gene is carried on the X chromosome.
X-linked
recessive Pathogenic variants in both copies of a gene on the X chromosome cause an X-linked recessive disorder.
recessive Pathogenic variants in both copies of a gene on the X chromosome cause an X-linked recessive disorder.
Mitochondrial or multigenic Mitochondrial genetic disorders can be caused by changes (mutations) in either the mitochondrial DNA or nuclear DNA that lead to dysfunction of the mitochondria and inadequate production of energy.
Multigenic or multifactor Inheritance involving many factors, of which at least one is genetic but none is of overwhelming importance, as in the causation of a disease by multiple genetic and environmental factors.
Not applicable
Other names (AKA)
Sexual precocity; Idiopathic sexual precocity; Familial precocious puberty
Summary
Precocious puberty is when a person's sexual and physical
Symptoms
This table lists symptoms that people with this disease may have. For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. This information comes from a database called the Human Phenotype Ontology (HPO) . The HPO collects information on symptoms that have been described in medical resources. The HPO is updated regularly. Use the HPO ID to access more in-depth information about a symptom.
Medical Terms | Other Names |
Learn More:
HPO ID
|
---|---|---|
5%-29% of people have these symptoms | ||
Hypothyroidism |
Underactive thyroid
|
0000821 |
Percent of people who have these symptoms is not available through HPO | ||
0000006 | ||
Elevated circulating follicle stimulating |
0008232 | |
Elevated circulating luteinizing hormone level | 0011969 | |
Isosexual precocious puberty | 0008236 | |
Decreased body height
Small stature
[ more ] |
0004322 |
Treatment
FDA-Approved Treatments
The medication(s) listed below have been approved by the Food and Drug Administration (FDA) as orphan products for treatment of this condition. Learn more orphan products.
- Leuprolide acetate(Brand name: Lupron (injection)) Manufactured by Abbott
FDA-approved indication: Treatment of children with central precocious puberty.
National Library of Medicine Drug Information Portal
Medline Plus Health Information - Histrelin acetate(Brand name: Supprelin LA (implant)) Manufactured by Endo Pharmaceuticals
FDA-approved indication: Treatment of central precocious puberty.
National Library of Medicine Drug Information Portal - Histrelin (Brand name: Supprelin® LA) Manufactured by Endo Pharmaceuticals
FDA-approved indication: Treatment of central precocious puberty
National Library of Medicine Drug Information Portal - Nafarelin acetate(Brand name: Synarel (nasal solution)) Manufactured by Pfizer
FDA-approved indication: Treatment of central precocious puberty (gonadotropin-dependent precocious puberty) in children of both sexes.
National Library of Medicine Drug Information Portal
Medline Plus Health Information
Learn more
These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.
Where to Start
- Mayo Clinic provides information on precocious puberty. Click on the link above to access this information.
- MedlinePlus was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.
In-Depth Information
- Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
- The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
- Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.
- PubMed is a searchable database of medical literature and lists journal articles that discuss Precocious puberty. Click on the link to view a sample search on this topic.
References
- Precocious puberty. Medline Plus. 2011; https://www.nlm.nih.gov/medlineplus/ency/article/001168.htm. Accessed 12/21/2012.
- Pasquino AM, Pucarelli I, Accardo F, et al.. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.. J. Clin Endocrin Met. 2008; 93:190-5. https://www.ncbi.nlm.nih.gov/pubmed/17940112. Accessed 12/21/2012.
- Carel JC, Eugster E, Rogal A, et al. Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children. Pediatrics. 2009; 123:752-762. https://pediatrics.aappublications.org/content/123/4/e752.long. Accessed 12/21/2012.
Rare Immunology News